INDEX— VOLUME II STARTS ON PAGE 971 



Calf diphtheria, 479, 1787 



Calmette-Guerin's bacillus (B.C.G.), 1306, 



1331, 1337, 1347 

 Calves. See Cattle 

 Canary-pox, 953, 1896 

 Canine typhus of Lukes, 1837 

 Capillaries, cerebfal, permeability of, 1060, 

 1754, 1764 

 permeability of, 1042 

 Capsules, bacterial, 29 



aggressive action of bacteria, in relation 

 to, 1072 

 hyaluronic acid in, 1072 

 in relation to virulence, 300, 575, 842, 

 1072 

 Carbohydrate constituents of bacteria, 44 



metabolism of bacteria, 51 

 Carbohydrates, action of bacteria on, 52-55 

 protein-sparing effect of in bacterial meta- 

 bolism, 57 

 synthesis of, by bacteria, 55 

 Carbon dioxide, as essential nutrient for bac- 

 teria. 61, 69 

 use of in blood culture, 1491, 1703 

 Carbon dioxide : hydrogen ratio, in differen- 

 tiation of coli-serogenes group, 661 

 in growth of Brucella, 818 

 role of in bacterial growth, 69 

 Carhoxydomonas oligocarbophila, 505 

 Carrier epidemic, 1251. See also Garriers under 



individual diseases 

 Carrier types of pneumococci, 1673 

 Carriers, bacterial. See under individual diseases 

 herd infection in relation to, 1246 

 in experimental epidemics, 1253 

 Catalase, methods of examination for, 369 



protective action of in relation to hydro- 

 gen peroxide, 72 

 Cataphoresis of bacteria, 213 

 of filtrable viruses, 950 

 of serum proteins, 242, 246, 248, 1030, 

 1092, 1385 

 Catarrh, malignant, of cattle, 1966 

 Cathode rays, effect of on bacteria, 108 

 Cations, effect of on bacteria, 123 

 Cats, Brucella infection in, 1719 

 distemper in, 1877 

 enteritis in, 1963 

 tuberculosis in, 427, 429, 1343 

 Cattle, actinomycosis in, 1271, 1276 



anaerobic infections of. See Anaerobic 



infections of animals 

 autumn diarrhoea in, 1720 

 bacillary hsemoglobinuria of, 891 

 blackleg in, 884, 885, 1778 

 botriomycosis in, 1492 

 botulism in, 1621 

 Brucella infections of, 1708-1716 



with Br. abortus. See Abortion, con- 

 tagious, in cattle 

 with Br. melitensis, 1697, 1710, 1711 

 with Br. suis, 1710, 1711 

 bulbar paralysis of, 1621 

 cow-pox of, 1888 

 diphtheria in, 1390 



diphtheria of calves due to F. necro- 

 phorus, 1787 



Cattle, diphtheroid infections of, 458-462, 

 1403 

 dry bible of, 1621 

 ephemeral fever of, 1966 

 epizootic pneumonia of calves, 391, 1281 

 farcy of, 387, 1276 

 ictero-hseraoglobinuria of, 1621 

 impaction paralysis of, 1621 

 influenzal pneumonia of calves, 1662. See 



also Scours 

 Johne's disease of, 441, 1363 

 lamziekte of, 880, 1621 

 malignant catarrh of, 1966 

 mastitis in, 1493. See Mastitis in cattle 

 Midland disease of, 1621 

 plague, 1965 



pleuropneumonia of, 939, 1647, 1867 

 pneumonia of calves due to Actino- 



bacillus actinoides, 1281 

 pyelitis in, 461 

 pyelonephritis in, 1500 

 red- water disease of, 891 

 Salmonella \niect\on^ of, 1600 

 scours in, 527, 667, 1662. See also In- 

 fluenzal pneumonia of calves 

 tuberculosis in, 1317, 1342-1348 

 Cellobiose, in differentiation of coli-serogenes 



group, 664 

 Cellular hypothesis of anaphjdactic shock, 1 145 

 immunity, role of in virus infections, 1234 

 reactions in bacterial infection, 1007 

 Cellulitis, 1493 



anaerobic, 1771 

 Centrifugation, factors affecting, 953 

 Centrifuges, types of, 953 

 Cerebrospinal meningitis. See Meningitis 

 Chancre, hard, 1812 et seq. 



soft, 1790 

 Cheese in relation to typhoid fever, 1542 



to undulant fever, 1701 

 Chemical changes produced by bacteria, 51 



et seq. 

 Chemical constitution of bacteria, 42 

 Chemistry of bacterial antigens. iS'ee under 



individual organisms 

 Chemotaxis in pyogenic infections, 1007 

 Chemotherapeutic activity, acidic or basic 

 groups, 170 

 and relation to chemical structure, 156, 

 169 

 in the sulphonamide series, 167 

 as interference with essential metabolites, 



162 

 surface activity and chain length, 170, 171 

 Chemotherapeutic agents, acquired resistance 

 of micro-organisms to, 156, 160, 172, 181 

 antagonizer — mhibitor systems, 159, 161 

 nicotinamide and sulphathiazole, 165 

 nicotinic acid and pyridine sulphona- 

 mide, 163 

 pantothenic acid and pantoyltaurme, 



164 

 ^-aminobenzoic acid and the sul- 



phonamides, 161 

 thiamin and pyrithiamin, 164 

 antagonizers of, 159, 161, 165 

 as inhibitors of bacterial growth, 159 



